Episode 61
Biotech Hangout
00:00
The Rise of Skepticism in Oncology
Timothy Stanley: I think there is a lot of optimism right now in terms of how disciplined private equity and venture capitalists are getting. You're seeing this kind of game of musical chairs. Everybody's trying to get their series B's. They're executing. These aren't flawed companies, but there's just not enough capital to support all of the inventory we created. It looks like we're beginning to see some buds on the public side, but you'll see it as we track biotechs at high prices.
Transcript
Play full episode
